Literature DB >> 25448734

Post-hoc comparison of vitamin D status at three timepoints during pregnancy demonstrates lower risk of preterm birth with higher vitamin D closer to delivery.

C L Wagner1, C Baggerly2, S L McDonnell2, L Baggerly2, S A Hamilton3, J Winkler3, G Warner3, C Rodriguez3, J R Shary4, P G Smith4, B W Hollis4.   

Abstract

There have been observational reports that maternal vitamin D status at baseline and not closest to delivery is a better predictor of pregnancy outcomes, suggesting that a cascade of events is set into motion that is not modifiable by vitamin D supplementation during later pregnancy. To address this issue, in this exploratory post-hoc analysis using correlation and logistic regression, we sought to measure the strength of the association between serum 25(OH)D concentrations at 3 timepoints during pregnancy: baseline, 1st trimester (<16 weeks); 2nd trimester (16-26 weeks); and 3rd trimester (≥27 weeks) and preterm birth. It was hypothesized that the 25(OH)D value closest to delivery would be most significantly associated with preterm birth. To accomplish this objective, the datasets from NICHD (n=333) and Thrasher Research Fund (n=154) vitamin D supplementation pregnancy studies were combined. The results of this analysis were that 25(OH)D values closer to delivery were more strongly correlated with gestational age at delivery than earlier values: 1st trimester: r=0.11 (p=0.02); 2nd trimester: r=0.08 (p=0.09); and 3rd trimester: r=0.15 (p=0.001). When logistic regression was performed with preterm birth (<37 weeks) as the outcome and 25(OH)D quartiles as the predictor variable, adjusting for study and participant race/ethnicity, as with the correlation analysis, the measurements closer to delivery were more significantly associated and had a higher magnitude of effect. That is, at baseline, those who had serum concentrations <50nmol/L (20ng/mL) had 3.3 times of odds of a preterm birth compared to those with serum concentrations ≥100nmol/L (40ng/mL; p=0.27). At 2nd trimester, the odds were 2.0 fold (p=0.21) and at the end of pregnancy, the odds were 3.8 fold (p=0.01). The major findings from this exploratory analysis were: (1) maternal vitamin D status closest to delivery date was more significantly associated with preterm birth, suggesting that later intervention as a rescue treatment may positively impact the risk of preterm delivery, and (2) a serum concentration of 100nmol/L (40ng/mL) in the 3rd trimester was associated with a 47% reduction in preterm births. This article is part of a Special Issue entitled '17th Vitamin D Workshop'.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cholecalciferol; Pregnancy; Preterm birth; Vitamin D

Mesh:

Substances:

Year:  2014        PMID: 25448734      PMCID: PMC4415820          DOI: 10.1016/j.jsbmb.2014.11.013

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  17 in total

1.  Maternal vitamin D status and spontaneous preterm birth by placental histology in the US Collaborative Perinatal Project.

Authors:  Lisa M Bodnar; Mark A Klebanoff; Alison D Gernand; Robert W Platt; W Tony Parks; Janet M Catov; Hyagriv N Simhan
Journal:  Am J Epidemiol       Date:  2013-10-11       Impact factor: 4.897

2.  Maternal vitamin D status and the risk of mild and severe preeclampsia.

Authors:  Lisa M Bodnar; Hyagriv N Simhan; Janet M Catov; James M Roberts; Robert W Platt; Jill C Diesel; Mark A Klebanoff
Journal:  Epidemiology       Date:  2014-03       Impact factor: 4.822

3.  Effect of vitamin D supplementation during pregnancy on foetal growth.

Authors:  R K Marya; S Rathee; V Dua; K Sangwan
Journal:  Indian J Med Res       Date:  1988-12       Impact factor: 2.375

4.  Effects of vitamin D supplementation in pregnancy.

Authors:  R K Marya; S Rathee; V Lata; S Mudgil
Journal:  Gynecol Obstet Invest       Date:  1981       Impact factor: 2.031

5.  First trimester vitamin D, vitamin D binding protein, and subsequent preeclampsia.

Authors:  Camille E Powe; Ellen W Seely; Sarosh Rana; Ishir Bhan; Jeffrey Ecker; S Ananth Karumanchi; Ravi Thadhani
Journal:  Hypertension       Date:  2010-08-23       Impact factor: 10.190

6.  Maternal vitamin D intake and mineral metabolism in mothers and their newborn infants.

Authors:  F Cockburn; N R Belton; R J Purvis; M M Giles; J K Brown; T L Turner; E M Wilkinson; J O Forfar; W J Barrie; G S McKay; S J Pocock
Journal:  Br Med J       Date:  1980-07-05

7.  Vitamin D supplements in pregnant Asian women: effects on calcium status and fetal growth.

Authors:  O G Brooke; I R Brown; C D Bone; N D Carter; H J Cleeve; J D Maxwell; V P Robinson; S M Winder
Journal:  Br Med J       Date:  1980-03-15

8.  Vitamin D supplements enhance weight gain and nutritional status in pregnant Asians.

Authors:  J D Maxwell; L Ang; O G Brooke; I R Brown
Journal:  Br J Obstet Gynaecol       Date:  1981-10

9.  Maternal vitamin D deficiency increases the risk of preeclampsia.

Authors:  Lisa M Bodnar; Janet M Catov; Hyagriv N Simhan; Michael F Holick; Robert W Powers; James M Roberts
Journal:  J Clin Endocrinol Metab       Date:  2007-05-29       Impact factor: 5.958

10.  Vitamin D supplementation in pregnancy: a controlled trial of two methods.

Authors:  E Mallet; B Gügi; P Brunelle; A Hénocq; J P Basuyau; H Lemeur
Journal:  Obstet Gynecol       Date:  1986-09       Impact factor: 7.661

View more
  33 in total

Review 1.  Maternal vitamin D levels during pregnancy and neonatal health: evidence to date and clinical implications.

Authors:  Spyridon N Karras; Hana Fakhoury; Giovanna Muscogiuri; William B Grant; Johannes M van den Ouweland; Anna Maria Colao; Kalliopi Kotsa
Journal:  Ther Adv Musculoskelet Dis       Date:  2016-07-13       Impact factor: 5.346

Review 2.  Vitamin D status during pregnancy: time for a more unified approach beyond borders?

Authors:  S N Karras; P Anagnostis; S A Paschou; E Kandaraki; D G Goulis
Journal:  Eur J Clin Nutr       Date:  2015-03-18       Impact factor: 4.016

Review 3.  Vitamin D in pregnancy: current perspectives and future directions.

Authors:  Mairead Kiely; Andrea Hemmingway; Karen M O'Callaghan
Journal:  Ther Adv Musculoskelet Dis       Date:  2017-05-02       Impact factor: 5.346

4.  Maternal serum vitamin D levels and preterm delivery among low-risk parturients in Lagos, Nigeria.

Authors:  Ayodeji A Oluwole; Kehinde S Okunade; Osemen E Okojie
Journal:  Int J Gynaecol Obstet       Date:  2018-12-10       Impact factor: 3.561

Review 5.  Vitamin D and its impact on maternal-fetal outcomes in pregnancy: A critical review.

Authors:  Shreya Agarwal; Oormila Kovilam; Devendra K Agrawal
Journal:  Crit Rev Food Sci Nutr       Date:  2017-06-28       Impact factor: 11.176

6.  Severe Vitamin D Deficiency in Human Immunodeficiency Virus-Infected Pregnant Women is Associated with Preterm Birth.

Authors:  Jennifer Jao; Laura Freimanis; Marisa M Mussi-Pinhata; Rachel A Cohen; Jacqueline Pontes Monteiro; Maria Leticia Cruz; Andrea Branch; Rhoda S Sperling; George K Siberry
Journal:  Am J Perinatol       Date:  2016-10-07       Impact factor: 1.862

7.  Prenatal Primary Prevention of Mental Illness by Micronutrient Supplements in Pregnancy.

Authors:  Robert Freedman; Sharon K Hunter; M Camille Hoffman
Journal:  Am J Psychiatry       Date:  2018-03-21       Impact factor: 18.112

Review 8.  Vitamin D during pregnancy: why observational studies suggest deficiency and interventional studies show no improvement in clinical outcomes? A narrative review.

Authors:  S N Karras; P Anagnostis; D Naughton; C Annweiler; A Petroczi; D G Goulis
Journal:  J Endocrinol Invest       Date:  2015-07-29       Impact factor: 4.256

Review 9.  Ultraviolet radiation and effects on humans: the paradigm of maternal vitamin D production during pregnancy.

Authors:  A Anastasiou; S N Karras; A Bais; W B Grant; K Kotsa; D G Goulis
Journal:  Eur J Clin Nutr       Date:  2016-09-28       Impact factor: 4.016

Review 10.  Maternal and fetal vitamin D and their roles in mineral homeostasis and fetal bone development.

Authors:  B A Ryan; C S Kovacs
Journal:  J Endocrinol Invest       Date:  2020-08-09       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.